Welcome to our dedicated page for PKPH news (Ticker: PKPH), a resource for investors and traders seeking the latest updates and insights on PKPH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PKPH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PKPH's position in the market.
Peak Pharmaceuticals (OTC Pink:PKPH) has merged with Retrieve Medical, Inc., transforming into an innovative software company focused on clinical documentation improvement. The merger, finalized on March 27, 2023, allows Peak to obtain 100% of Retrieve's capital stock, issuing approximately 16.3 million shares representing 86% of Peak's outstanding shares. This acquisition enhances physicians' diagnostic capabilities through Retrieve's patented Clinical Documentation Improvement (CDI) platform, utilized by major electronic medical record providers Epic and Cerner. The company will rebrand as Retrieve Medical Holdings, Inc. and aims for expansion across U.S. healthcare providers.
Peak Pharmaceuticals, Inc. (OTC Pink:PKPH) announced a 1-for-200 reverse stock split effective February 15, 2023. This means that every 200 pre-split shares will combine into one new share of common stock, reducing the total outstanding shares from 78,363,567 to 391,818. The new shares will trade under the symbol PKPHD with a new CUSIP number, 70469W205. There will be no fractional shares issued; any fractional shares will be rounded up to the nearest whole share. This move aims to consolidate the stock and may impact its trading dynamics on the OTC Pink Market.
FAQ
What is the market cap of PKPH (PKPH)?
